India News: NEW DELHI: Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of anti-COVID drug 2-deoxy-D-g.
DRDO to launch 2-DG drug for COVID-19 treatment next week
The first batch of 10,000 doses of 2DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials
BusinessToday.In | May 15, 2021 | Updated 11:53 IST
The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence
The first tranche of 10,000 doses of 2-DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials on Friday, May 14.
The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad.
Source:
Highlights
The first batch of 10,000 doses of the 2-DG drug would be launched early next week, informed DRDO on May 14.
The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and reduces oxygen dependence.
New Delhi: The first batch of 10,000 doses of the 2-DG drug for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday (May 14, 2021).
The official informed, The first batch of 10,000 doses of 2-DG medicine for the treatment of COVID-19 infected patients would be launched early next week and will be given to patients. The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt , informed DRDO officials.
The first batch of 10,000 doses of 2DG medicine for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday. The official informed, The first batch of 10,000 doses of 2DG medicine for the treatment of COVID-19 infected patients would be launched early next week and will be given to patients. The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt , informed DRDO officials. Yesterday, Karnataka Health Minister Dr K Sudhakar visited DRDO campus.DRDO scientists briefed Minister about the 2-DG drug which could be a game-changer in the COVID-19 battle.
DRDO s 2DG medicine for treating COVID-19 patients to be launched next week ANI | Updated: May 15, 2021 02:56 IST
New Delhi [India], May 15 (ANI): The first batch of 10,000 doses of 2DG medicine for treating COVID-19 patients would be launched early next week, informed Defence Research and Development Organisation officials on Friday.
The official informed, The first batch of 10,000 doses of 2DG medicine for the treatment of COVID-19 infected patients would be launched early next week and will be given to patients. The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt , informed DRDO officials.